Skip to main content

Month: May 2020

Euro Manganese leistet Abschlusszahlung für den Erwerb des Chvaletice Manganprojekts

EMN zahlt letzte Kaufpreisrate für das Chvaletice ManganprojektEMN beteiligt sich an der online durchgeführten Benchmark Mineral Intelligence World TourVANCOUVER, British Columbia, May 15, 2020 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V/ASX: EMN) (das „Unternehmen“ oder „EMN“) freut sich bekannt zu geben, dass es in Verbindung mit dem Erwerb seiner hundertprozentigen Tochtergesellschaft, die alle Rechte am Chvaletice Manganprojekt besitzt, die letzte Tranche von Stammaktien ausgegeben hat („Aktien“) und dass sein Präsident und CEO auf der Benchmark Mineral Intelligence World Tour online vortragen wird.Letzte Tranche von Aktien ausgegeben zum Erwerb von Mangan Chvaletice s.r.o.Am 13. Mai 2020 gab das Unternehmen 3.333.333 Aktien an die Gründungsaktionäre von Mangan Chvaletice s.r.o. („Mangan“) aus, um gemäß der Vereinbarung vom...

Continue reading

Skyline Announces Operational Results for Q1 2020 and Provides COVID-19 Operational Update

Q1 2020 adjusted EBITDA was C$9.1 million compared to C$12.6 million in Q1 2019;Q1 2020 revenue was C$71.7 million compared to C$56.9 million in Q1 2019, driven by completion of development projects;Same asset NOI decreased by C$5.3 million to C$7.5 million compared to C$12.3 million in Q1 2019, driven by the effects of COVID-19;The Company repurchased 219.7 thousand NIS (approximately C$87.9 thousand) worth of bonds at an average price of 79.56 NIS subsequent to quarter end;Total cash and available lines of credit as at March 31, 2020 totalled approximately C$40 million; andSkyline is responding aggressively to the impact of COVID-19 and has significant cash and other resources to reasonably manage through the pandemic.TORONTO, May 15, 2020 (GLOBE NEWSWIRE) — Skyline Investments Inc. (the “Company” or “Skyline”) (TASE: SKLN), a Canadian...

Continue reading

Euro Sun Mining Announces Upsizing of Previously Announced Bought Deal Public Offering of Units

Not for distribution to United States newswire services or dissemination in the United States.TORONTO, May 15, 2020 (GLOBE NEWSWIRE) — Euro Sun Mining Inc. (TSX: ESM) (“Euro Sun” or the “Company”) announces that it has entered into an amending agreement with Sprott Capital Partners LP on its own behalf and, if applicable, on behalf of a syndicate of underwriters (together, the “Underwriter”) pursuant to which the Underwriter has agreed to purchase, on a bought deal basis, 51,282,052 units of the Company (the “Units”) at a price of C$0.39 per Unit (the “Issue Price”) for gross proceeds of approximately C$20,000,000 (the “Offering”).  Each Unit is comprised of one (1) common share in the capital of the Company (each, a “Common Shares”) and one half of one Common Share purchase warrant (each whole warrant, a “Warrant”) entitling the...

Continue reading

ADC Therapeutics annonce le prix de son introduction en bourse augmentée

LAUSANNE, Suisse, 15 mai 2020 (GLOBE NEWSWIRE) — ADC Therapeutics SA, une société de biotechnologie spécialisée dans l’oncologie au stade clinique avancé et pionnière dans le développement et la commercialisation de conjugués anticancéreux extrêmement puissants et ciblés pour les patients atteints d’hémopathies malignes et de tumeurs solides, a annoncé aujourd’hui la tarification de son introduction en bourse de 12 245 631 de ses actions ordinaires au prix de 19 $ par action. Le produit brut cumulé issu de l’offre, avant déduction des remises et commissions liées à la souscription et autres frais d’offre estimés dus par ADC Therapeutics, devrait atteindre environ 232,7 millions $. Les actions devraient commencer à être négociées à la Bourse de New York le 15 mai 2020 sous le symbole « ADCT ». La clôture...

Continue reading

ADC Therapeutics gibt Kurs seiner aufgestockten Erstplatzierung an der Börse bekannt

LAUSANNE, Schweiz, May 15, 2020 (GLOBE NEWSWIRE) — ADC Therapeutics SA, ein im Bereich der späten klinischen Forschung tätiges Biotechnologieunternehmen mit Schwerpunkt Onkologie und Vorreiter in der Entwicklung und Vermarktung von hochwirksamen und zielgerichteten Antikörper-Wirkstoff-Konjugaten für die Behandlung von Patienten mit hämatologischen Malignomen und soliden Tumoren, hat heute den Kurs der Erstplatzierung von 12.245.631 Anteilen seiner Stammaktien an der Börse von 19,00 USD je Anteil bekannt gegeben. Die Bruttoerlöse aus dem Börsengang vor Abzug der von ADC Therapeutics zu zahlenden Unterzeichnungsabschläge und Provisionen und geschätzter Ausgaben für die Wertpapierausgabe belaufen sich voraussichtlich auf ca. 232,7 Mio. USD. Die Aktien können voraussichtlich ab dem 15. Mai 2020 an der New York Stock Exchange unter...

Continue reading

IMCD to acquire the pharmaceutical business of Develing International Trade (Shanghai) Co. Ltd

ROTTERDAM, The Netherlands (15 May 2020) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and food ingredients, today announces that it has signed an agreement to acquire the pharmaceutical business in China of Develing International Trade (Shanghai) Co. Ltd. (“Develing”) upon fulfilment of transaction-related conditions.Develing International with head office in Shanghai, is a Dutch sales and distribution company (B2B) of high-quality ingredients for the food, pharmaceutical, chemical, and feed industry in China and Vietnam.  The acquired business with annual sales of approximately € 10 mln will be integrated into IMCD China’s business unit Pharma and will be synergistic with IMCD’s existing product range.

Continue reading

Data443 Risk Mitigation Reports Operating Results for the Quarter Ended March 31, 2020

RALEIGH, N.C., May 15, 2020 (GLOBE NEWSWIRE) — Data443 Risk Mitigation, Inc. (OTCPK: ATDS), a leading data security and privacy software company, today announced operating results for the quarter ended March 31, 2020:Recent Business Highlights:No customer or contract losses due to COVID-19 conditionsStaff and business operations retained and on scopeReleased the CCPA version of the GDPR Framework for WordPress to the publicRapidly changed business operations to adapt to new conditions due to COVID-19 emergencyNew Data Center online and consolidation project nearing completionSecond version of Global Privacy Manager™ available for private betaPublic shopping cart ordering platform launched – more product line being added weeklyLarger SMB & B2C marketing campaigns being launched starting Q2Financial Highlights from Q1 2020:Continued...

Continue reading

Parker Scheduled to Present at the Wolfe Research Global Transportation & Industrials Virtual Conference on May 19 at 11:15 a.m. Eastern Time

CLEVELAND, May 15, 2020 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at the Wolfe Research Global Transportation and Industrials Virtual Conference on May 19, 2020 at 11:15 a.m. Eastern time.Parker’s scheduled presenter is Tom Williams, Chairman and Chief Executive Officer.  A live webcast of the presentation will be accessible on Parker’s investor information website at www.phstock.com and will be archived on the site.Parker Hannifin is a Fortune 250 global leader in motion and control technologies.  For more than a century the company has been enabling engineering breakthroughs that lead to a better tomorrow.  Parker has increased its annual dividend per share paid to shareholders for 64 consecutive fiscal...

Continue reading

Verkkokauppa.com Oyj: Share repurchase 15 May 2020

Verkkokauppa.com Oyj     COMPANY RELEASE       15 May 2020 at 21:00 EETVerkkokauppa.com Oyj: Share repurchase 15 May 2020In the Helsinki Stock ExchangeCompany now holds a total of 80,651 sharesincluding the shares repurchased on 15 May 2020.On behalf of Verkkokauppa.com OyjDANSKE BANK AS, SUOMEN SIVULIIKE For more information, please contact:Mikko Forsell, CFOmikko.forsell@verkkokauppa.comPuh. +358 10 309 5555AttachmentVerkkokauppa.com Oyj Share repurchases 15.5

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.